Axelrod Research — LMT: The $58.6bn Patriot Backlog Still Supports a Buy
No new company evidence landed in today’s research window, so the useful decision is whether Lockheed Martin’s existing case still clears the bar. It does: the verified Patriot award remains unusually visible demand, and LMT’s $535.40 close on 21 September 2026 remains below the prior $600 entry ceiling. The call is unchanged from 17 September because neither the evidence nor the valuation trigger has moved enough to justify a revision.[1][2]
LMT — BUY
Why now. This is a re-underwrite, not a new catalyst call. The U.S. Army’s Patriot PAC-3 MSE contract has a ceiling of $58.6bn over roughly seven years through about 2032, with production intended to triple; the latest available market close was $535.40 on 21 September 2026.[1][2]
The evidence. The July 2026 research established the award as a verified $58.6bn ceiling and tied the benefit directly to Lockheed’s Missiles and Fire Control business. It also identified the real underwriting gap: the award secures demand, but does not by itself prove revenue timing or margin. That distinction still carries the call.[1][3]
Levels & triggers. Buy below $600 while the contract remains intact. Confirmation requires quarterly evidence that PAC-3 MSE output is rising without Missiles and Fire Control margin deterioration; a sustained production shortfall, material cost overrun, or contract reduction kills the thesis.[1][3]
Horizon. 18–36 months: long enough for the production ramp to appear in deliveries and segment economics, but shorter than the contract’s full term.[1]
The bear case. A $58.6bn ceiling is not $58.6bn of guaranteed profitable revenue. Supply-chain strain and the cost of tripling output could turn backlog visibility into weak incremental returns, especially if contract pricing leaves Lockheed carrying overruns.[1][3]
What I’m watching: the next Lockheed filing and earnings deck for PAC-3 MSE delivery growth and Missiles and Fire Control margin—the two facts that would either validate the backlog or break the call.
Sources
Independent equity analysis, for information only, not investment advice.